08Mar 2021
Therapeutic pipeline in nonalcoholic steatohepatitis

Therapeutic pipeline in nonalcoholic steatohepatitis

The therapeutic pipeline for nonalcoholic steatohepatitis (NASH) is expanding as insights into disease pathophysiology are gained. This Review summarizes progress in the development of NASH therapies, current and ongoing clinical trials, and potential challenges with emerging therapies.

  • #gastroenterology

Like

Save

Share